Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
WTW’s ICT appoints Nicholas Carbo as Senior Director in North America
-
Micron Updates Fourth Quarter Fiscal 2025 Guidance
-
Catheter Precision, Inc. Reports Results of Operations for Second Quarter 2025
-
Inspire Medical Systems, Inc. Board Authorizes Share Repurchase Program
-
GBT Technologies Intends to Rebrand as Wertheim & Company; Craig Marshak Appointed CEO; Emil Assentato Joins as Strategic Investor
-
4DMT Reports Second Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
-
Gabelli Funds to Host 31st Annual Aerospace & Defense Symposium at The Harvard Club, New York City Thursday, September 4, 2025
-
Crestone Air Partners Launches Blue Crest Aviation Partners with funds managed by Blue Owl
-
vTv Therapeutics Announces USPTO Allowance of Patent Covering Cadisegliatin
-
Schouw & Co. share buy-back programme, week 32 2025
-
JDE Peet’s share buyback periodic update August 11, 2025
-
Mevolaxy Announces Record Payouts in June
-
Xtreme Asset Management Announces it is Expanding its Global Investment Reach in 2025 with Enhanced Institutional Partnerships
-
Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial
-
Net Asset Value(s)
-
MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results
-
Rail Vision Receives European Patent for Innovative Locomotive Imaging Technology
-
Correction: AS Tallinna Sadam financial results for 2025 Q2 and 6 months
-
Nexxen Renews and Expands its Strategic Partnership with VIDAA, with a Focus on Growing VIDAA’s North American CTV Footprint
-
L.B. Foster Announces Strong Second Quarter Results with Organic Growth and Profitability Expansion Expected to Continue Through Balance of 2025
-
Winshear Enters Option Agreement on the Portsoy Nickel – Copper – Cobalt Project, Scotland
-
Matador Acquires 5 Bitcoin for CAD$802,020, Bringing Its Total Bitcoin (and Bitcoin Equivalent) Holdings to 77.4
-
MAX Power Partners with Caram Media and TMI Digital to Drive Strategic Marketing and Spotlight Natural Hydrogen Story
-
Altimmune Board of Directors Appoints Jerry Durso as Chairman
-
Fox River Announces Funding Award from the Critical Minerals Innovation Fund
-
Avicanna Announces US Patent and Trademark Office Issuance of New Patent
-
Nayax Announces Strategic Partnership with Leading Global EVSE Provider Autel Energy to Deliver Embedded Payment Solutions
-
Magna to Showcase Its Vision for Safer, Smarter, Greener Mobility at IAA Mobility 2025
-
Exodus and MetaMask Partner to Bring XO Swap’s Bridge Functionality to Millions of Wallet Users
-
MiniLuxe Announces Planned Share Issuance for a New Studio Location Acquisition in the DFW (Dallas Fort Worth) Region
-
Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025
-
Lithium Argentina Reports Second Quarter 2025 Results
-
Kinross Files Early Warning Report with respect to Asante Gold
-
Kraig Biocraft Laboratories to Launch Operations at New Southeast Asia Production Facility This Week
-
Plum Role Model™ Named a 2025 Top HR Product of the Year by HR Executive
-
American Tungsten Provides Update on Site Rehabilitation Progress and Federal Engagement
-
Papa Johns Canada Brings Hawaii Home with The Aloha Trio
-
Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030
-
NBB, a leading Automotive M&A Advisory firm, Names Experienced Investment Banker Zach Kuzemka as new Chief Executive Officer
-
BioCryst Announces Departure of Dr. Helen Thackray
-
Kamada Announces FDA Approval of its Plasma Collection Center in Houston, Texas
-
Rocky Shore Gold Announces Non-Brokered Private Placement
-
NBB, a leading Automotive M&A Advisory firm, Names Experienced Investment Banker Zach Kuzemka as new Chief Executive Officer
-
WeightWatchers Announces Second Quarter 2025 Results
-
Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2025 Financial Results
-
Asante Signs Definitive Agreements to Unlock Approximately $500M of Financing Proceeds
-
Humacyte Announces Second Quarter 2025 Financial Results and Provides Business Update
-
FoRx Therapeutics Initiates First-in-Human Trial with Novel Anti-Cancer Drug FORX-428 Targeting DNA Damage Response
-
Compass Therapeutics Reports 2025 Second Quarter Financial Results and Provides Corporate Update
-
I-Mab Completes Enrollment in Planned Phase 1b Dose Expansion Study for Givastomig in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers
